Perrigo (PRGO) Total Liabilities (2013 - 2026)
Perrigo (PRGO) posted quarterly Total Liabilities of $5.5 billion for Q1 2026, up 1.64% year-over-year from $5.4 billion in Q1 2025, and down 2.06% quarter-over-quarter from $5.6 billion in Q4 2025.
Perrigo (PRGO) Total Liabilities (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Total Liabilities for 14 consecutive years, with $5.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 1.64% year-over-year to $5.5 billion; the TTM figure through Mar 2026 stood at $5.5 billion (up 1.64% YoY), while the FY2025 annual figure was $5.6 billion, up 5.09% from the prior year.
- Total Liabilities slipped to $5.5 billion in Q1 2026 per PRGO's latest filing, from $5.6 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $6.6 billion in Q3 2024 and bottomed at $5.3 billion in Q2 2022.
- Historically, Total Liabilities has averaged $5.8 billion across 5 years, with a median of $6.0 billion in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities rose 17.09% — and 2025, when it declined 15.06%.
- Perrigo's Total Liabilities stood at $6.2 billion in 2022, then dropped by 2.17% to $6.0 billion in 2023, then decreased by 11.8% to $5.3 billion in 2024, then advanced by 5.09% to $5.6 billion in 2025, then decreased by 2.06% to $5.5 billion in 2026.
- Business Quant data shows PRGO's Total Liabilities at $5.5 billion in Q1 2026, $5.6 billion in Q4 2025, and $5.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Perrigo | 1.94 Bn | 1.54 Bn | 313.90 Mn | 5.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 5.09 Bn |
| Mar 28, 2026 | 5.48 Bn |
| Dec 31, 2025 | 5.60 Bn |
| Sep 27, 2025 | 5.64 Bn |
| Jun 28, 2025 | 5.62 Bn |
| Mar 29, 2025 | 5.40 Bn |
| Dec 31, 2024 | 5.33 Bn |
| Sep 28, 2024 | 6.64 Bn |
| Jun 29, 2024 | 5.85 Bn |
| Mar 30, 2024 | 5.95 Bn |
| Dec 31, 2023 | 6.04 Bn |
| Sep 30, 2023 | 6.02 Bn |
| Jul 1, 2023 | 6.12 Bn |
| Apr 1, 2023 | 6.12 Bn |
| Dec 31, 2022 | 6.18 Bn |
| Oct 1, 2022 | 6.07 Bn |
| Jul 2, 2022 | 6.07 Bn |
| Apr 2, 2022 | 5.29 Bn |
| Dec 31, 2021 | 5.27 Bn |
| Oct 2, 2021 | 5.73 Bn |